Risperdal / Invega Class Action

Merchant Law Group LLP has launched a Risperdal / Invega class action against the manufacturers of these pharmaceuticals on behalf of Canadian men who have developed gynecomastia (male breast tissue growth) after taking Risperdal or Invega.

Risperdal (risperidone) and Invega (paliperidone) are antipsychotic medications sold by Johnson & Johnson and approved by Health Canada to treat schizophrenia. However, these two drugs can cause serious side effects such as breast development in boys. Hundreds of boys who took these drugs suffered breast tissue enlargement, and some were forced to have surgery to remove the tissue.

The Risperdal / Invega drug class action seek proper financial compensation for affected Canadians. Please note, joining our contact list for the Risperdal / Invega Class Action creates no financial obligation for you and your information will be kept confidential. (If you have previously joined our contact list for this class action and your address or other contact information has changed, you may update your contact information on our list by completing the form below.)

IF YOU WISH TO JOIN THE CONTACT LIST FOR THIS CLASS ACTION (Please note, providing your information creates no financial obligation for you. You are not charged any fee or cost for joining this class action – we are simply paid a contingency fee from the compensation recovered, if successful.)